Endo-Porter: a novel reagent for safe, effective delivery of substances into cells
about
Steric antisense inhibition of AMPA receptor Q/R editing reveals tight coupling to intronic editing sites and splicingMina, an Il4 repressor, controls T helper type 2 biasCasein kinase 1 alpha regulates chromosome congression and separation during mouse oocyte meiotic maturation and early embryo development.Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity.Reverse signaling by glycosylphosphatidylinositol-linked Manduca ephrin requires a SRC family kinase to restrict neuronal migration in vivo.TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages.Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides.Circadian control of innate immunity in macrophages by miR-155 targeting Bmal1.Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicingMorpholino injection in Xenopus.Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy.The use of Endo-Porter to deliver morpholinos in kidney organ culture.Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges.Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation.Morpholino-mediated knockdown in primary chondrocytes implicates Hoxc8 in regulation of cell cycle progression.Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.Upregulation of proteasome activity rescues cardiomyocytes following pulse treatment with a proteasome inhibitor.Canonical and non-canonical barriers facing antimiR cancer therapeuticsExon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases.Peptides used in the delivery of small noncoding RNA.Using Morpholinos to Control Gene Expression.Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell.Functional peptides for siRNA delivery.Polyethyleneglycol crosslinked N-(2-hydroxyethyl)-polyethylenimine nanoparticles as efficient non-viral vectors for DNA and siRNA delivery in vitro and in vivo.Recent advances in functional perturbation and genome editing techniques in studying sea urchin development.Reverse signaling via a glycosyl-phosphatidylinositol-linked ephrin prevents midline crossing by migratory neurons during embryonic development in Manduca.Glucan particles for selective delivery of siRNA to phagocytic cells in mice.Using morpholinos to control gene expression.Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.A cationic morpholino antisense oligomer conjugate: synthesis, cellular uptake and inhibition of Gli1 in the hedgehog signalling pathway
P2860
Q24630687-CDBACEFE-FCD8-45CB-BE64-05F2DE7AEE5CQ28511123-C2BE2C2D-8BBD-4351-B59B-98EF705232F9Q31117769-CE02B328-E845-4B4F-9D20-74CB57701C4DQ34463222-E7D14478-0F4A-48F0-BCD1-18DAC6664E76Q35002087-057DED1E-E9E3-41A2-8AAD-ECD9CA51BC0CQ35041384-749108A3-A9AF-4A3F-9B47-73AA49C2AD4FQ35699768-25478CEA-6BB6-4BE5-9F6F-D8149C623BCBQ35740315-28A98A7B-53BA-44BA-B9B9-39D60E48FEE2Q36004826-6D982503-BD54-4325-BBB8-727B1B58DEE4Q36808239-BA0362E2-6FC1-45CC-9E7D-955F43EE9D9EQ37053612-0A8F916A-C874-43AA-8465-BABC6B2FBBD7Q37106925-2EA0315C-F7E4-4FB1-B9BF-B3921575A4F8Q37277330-C9875B4E-39C7-447E-B3B1-258060B3F940Q37278475-9635B248-B4D2-4397-94EB-8BC9C4CECB5AQ37383699-E8851B79-F872-4503-AC42-B91AC69CAF84Q37498037-0AF15E2D-BDF7-4D60-B48D-02FFAA46B910Q37587303-00587B08-3633-4A26-9AF9-4891C13E87F1Q38112723-452B922C-4662-43C0-A127-87FB9A1CFE49Q38186137-9EEDC657-6E02-47A8-880F-0EC182F97715Q38243361-FFF85012-C5F3-4E2D-A614-C1105819F906Q38288902-81557111-B32F-450E-836B-EE536C310EBAQ38494545-F3448F2E-F96A-4729-ADE1-19328EFCD55FQ38928987-6E2E1004-816D-4498-815E-D158D4E57487Q39133992-777709E9-1914-4132-B37D-8E98EF2C2B06Q39366973-26FC979F-FB17-4DE4-8BFC-741F4650BF42Q40855885-5FF55386-4844-448D-A796-D8E0820FE2A5Q42813063-A332E83E-64AA-4000-B67E-EF4F10CE0B37Q53481883-E811758B-EAD2-426D-8149-29B4716C8DFCQ55383414-64402E61-E88F-48C4-921D-D77D9C42F1E8Q57464951-625539A4-892E-42A7-95B6-AF34A49011F4
P2860
Endo-Porter: a novel reagent for safe, effective delivery of substances into cells
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Endo-Porter: a novel reagent for safe, effective delivery of substances into cells
@ast
Endo-Porter: a novel reagent for safe, effective delivery of substances into cells
@en
Endo-Porter: a novel reagent for safe, effective delivery of substances into cells
@nl
type
label
Endo-Porter: a novel reagent for safe, effective delivery of substances into cells
@ast
Endo-Porter: a novel reagent for safe, effective delivery of substances into cells
@en
Endo-Porter: a novel reagent for safe, effective delivery of substances into cells
@nl
prefLabel
Endo-Porter: a novel reagent for safe, effective delivery of substances into cells
@ast
Endo-Porter: a novel reagent for safe, effective delivery of substances into cells
@en
Endo-Porter: a novel reagent for safe, effective delivery of substances into cells
@nl
P3181
P356
P1476
Endo-Porter: a novel reagent for safe, effective delivery of substances into cells
@en
P2093
James E Summerton
P3181
P356
10.1196/ANNALS.1359.012
P407
P577
2005-11-01T00:00:00Z